HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Familial Osteochondritis Dissecans

Also Known As:

Osteochondritis Dissecans, Short Stature, and Early-Onset Osteoarthritis

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Musculoskeletal Diseases: 719
- Bone Diseases: 5863
  - Osteochondritis: 73
    - Osteochondritis Dissecans: 343
      - Familial Osteochondritis Dissecans: 2

Experts

1.	Aspberg, Anders: 2 articles (01/2022 - 02/2010)
2.	Lindblom, Karin: 2 articles (01/2022 - 02/2010)
3.	Stattin, Eva-Lena: 2 articles (01/2022 - 02/2010)
4.	Struglics, André: 2 articles (01/2022 - 02/2010)
5.	Carter, Erin: 1 article (01/2022)
6.	Davis, Jessica: 1 article (01/2022)
7.	Dixit, Abhijit: 1 article (01/2022)
8.	Goldblatt, Jack: 1 article (01/2022)
9.	Raggio, Cathleen: 1 article (01/2022)
10.	Randell, Tabitha: 1 article (01/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Familial Osteochondritis Dissecans:

1.	Aggrecans (Aggrecan)IBA 01/01/2022 - "Novel missense ACAN gene variants linked to familial osteochondritis dissecans cluster in the C-terminal globular domain of aggrecan." 02/12/2010 - "Our results provide a molecular mechanism for the etiology of familial osteochondritis dissecans and show the importance of the aggrecan C-type lectin interactions for cartilage function in vivo." 02/12/2010 - "A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans."
2.	C-Type Lectins (C-Type Lectin)IBA 02/12/2010 - "Our results provide a molecular mechanism for the etiology of familial osteochondritis dissecans and show the importance of the aggrecan C-type lectin interactions for cartilage function in vivo." 02/12/2010 - "A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans."